Therefore, our findings strongly indicated that SELENBP1 was an important tumor suppressor in the origin and development of NSCLC, and it may help to discover novel biomarkers or drug therapy targets for NSCLC. The gene discussed is SELENBP1; the disease is non-small cell lung carcinoma.